U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794099) titled 'Study on the Applicability of CCR Criteria in Rectal Cancer' on Jan. 21.
Brief Summary: This study aims to explore how well the usual ways of checking if rectal cancer patients are free of disease signs after treatment work for a new treatment method. The new method combines chemotherapy, radiation, and immune-boosting drugs before surgery. We know these usual ways work for the standard treatment, but we're not sure if they're good enough for this new combo treatment. We'll look at patients with a specific type of rectal cancer that doesn't respond well to just immune-boosting drugs alone. By comparing how patients treated with the ...